Outpatient abortion surgery
Conditions
Interventions
Group A8:Alfentanil13ug/kg + propofol 2.0mg/kg
Group A9:Alfentanil15.5ug/kg + propofol 2.0mg/kg
Group L1:Alfentanil 3.6ug/kg + propofol 2.0mg/kg + lidocaine 1mg/kg
Group L2:Alfentanil 4.3ug/kg + propofol 2.0mg/kg + lidocaine 1.0mg/kg
Group L3:Alfentanil 5.2ug/kg + propofol 2.0mg/kg + lidocaine 1.0mg/kg
Group A1:Alfentanil3.6ug/kg + propofol 2.0mg/kg
Group A2:Alfentanil4.3ug/kg + propofol 2.0mg/kg
Group A3:Alfentanil5.2ug/kg + propofol 2.0mg/kg
Group A4:Alfentanil6.2ug/kg + propofol 2.0mg/kg
Group A5:Alfentanil 7.5ug/kg + propofol 2.0mg/kg
Group A6:Alfentanil9.0ug/kg + propofol 2.0mg/kg
Group A7:Alfentanil10.8ug/kg + propofol 2.0mg/kg
Group L4:Alfentanil 6.2ug/kg + propofol 2.0mg/kg + lidocaine 1.0mg/kg
Group L5:Alfentanil 7.5ug/kg + propofol 2.0mg/kg + lidocaine 1.0mg/kg
Group L6:Alfentanil 9.0ug/kg + propofol 2.0mg/kg + lidocaine 1.0mg/kg
Group L7:Alfentanil 10.8ug/kg + propofol 2.0mg/kg + lidocaine 1.0mg/kg
Group L8:Alfentanil 13ug/kg + propofol 2.0mg/kg + lidocaine 1.0mg/kg
Group L9:Alfentanil 15.5ug/kg + propofol 2.0mg/kg + lidocaine 1.0mg/kg
Sponsors
Yuhang District Women and Children Care Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Agree to participate this study; aged 18-40 years; BMI18-28; ASAI grade-II female patients; within 60 days of Pregnancy; planned to undergo painless artificial abortion surgery.
Exclusion criteria
Exclusion criteria: Severe cardiovascular and cerebrovascular diseases; hepatitis; kidney disease, severe anemia and malnutrition; history of endocrine disease; history of chronic pain; history of mental illness or psychotropic drug dependence, patients who are allergic to alfentanil, propofol and lidocaine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body movement response;Vital signs;Drug dosage;Waking time; | — |
Countries
China
Contacts
Public ContactLinda Jin
Yuhang District Women and Children Care Hospital
Outcome results
None listed